Skip to content

Effect of auricular vagus nerve stimulation in Parkinson disease and freezing of Gait

Investigating the Effect of auricular vagus nerve stimulation on Target Gait improvement in patients with Parkinson disease and freezing of Gait

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20121110011424N6
Enrollment
54
Registered
2024-05-08
Start date
2024-06-19
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease. Parkinson's disease

Interventions

Intervention 1: Intervention group: Stimulation of the vagal branch of the ear (location of two electrodes: 1. right ear concha, 2. patients shoulder (in the form of a pad-like plate)) with a frequenc

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Hoehn & Yahr index between 2-3 able to walk 30 meters without help Has been treated with a stable dose of dopaminergic drugs in the last two months Able to follow simple verbal commands The patient can turn 180 degrees at one point The age of patients should be less than 76 years. The Montreal cognitive assessment index should be less than 21.

Exclusion criteria

Exclusion criteria: Presence of specific musculoskeletal disorders Heart problems, especially arrhythmias and having a pacemaker History of stroke and myocardial infarction Diabetes and neuropathy The presence of cognitive, vision and breathing problems that affect the performance of tasks Neurological disorders other than Parkinson's Surgery that affects the movement of patients. The patient needs assistance to walk. Body mass index above 30 A history of receiving vagus nerve stimulation Taking anticholinergic drugs or cholinesterase inhibitors Freezing of Gait for reasons other than Parkinson's

Design outcomes

Primary

MeasureTime frame
The improvement of movements and gait problems of parkinsonian patients with freezing. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Gate analysis with force plate and motion analyzer and MDS-UPDRS questionnaire.;Adverse effect. Timepoint: 2 weeks after intervention. Method of measurement: Adverse effect form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Samiee

Tehran University of Medical Sciences

Rezasamieepgh@gmail.com+98 17 3232 4159

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026